PALO ALTO, Calif.--(BUSINESS WIRE)--Theranos, Inc. today announced the appointment of William H. Frist, M.D., to its Board of Directors.
Senator Frist is a nationally recognized heart and lung transplant surgeon, former U.S. Senate Majority Leader, and Chairman of the Executive Council of Cressey and Company. Senator Frist represented Tennessee in the U.S. Senate for 12 years where he served on both the Health and Finance committees. He was elected Majority Leader of the Senate having served fewer total years in Congress than anyone in history. His leadership was instrumental to the passage of the 2003 Medicare Prescription Drug, Improvement and Modernization Act and PEPFAR, the unprecedented national commitment to fight HIV/AIDS globally.
Prior to the Senate, Dr. Frist spent 20 years in clinical medicine, completing surgical training at Massachusetts General Hospital and Stanford. He founded the Vanderbilt Multi-Organ Transplant Center and has performed over 150 heart and lung transplants. Currently a professor of surgery at both Vanderbilt University Medical Center and Meharry Medical School, he serves on the board of directors for the Robert Wood Johnson Foundation, Kaiser Family Foundation, and Harvard Medical School Board of Fellows, on the Advisory Committees for Global Health at both Duke and Harvard, and as co-chair of the Health Project for the Bipartisan Policy Center. Senator Frist is one of only two individuals to rank in the top ten of each of the five inaugural Modern Healthcare Magazine annual surveys of the most powerful people in healthcare in the United States.
Senator Frist joins existing Theranos Board members Elizabeth Holmes, Theranos Chairman and Chief Executive Officer; George P. Shultz; Gary Roughead; William J. Perry; Samuel Nunn; James Mattis; Richard Kovacevich; Henry A. Kissinger; Riley P. Bechtel; and Sunny Balwani, Theranos President and Chief Operating Officer.
Headquartered in Palo Alto, Theranos, Inc. is a consumer healthcare technology company. Theranos’ clinical laboratory offers comprehensive laboratory tests from samples as small as a few drops of blood at unprecedented low prices. Founded in 2003 by Elizabeth Holmes, Theranos’ mission is to make actionable health information accessible to people everywhere in the world at the time it matters, enabling early detection and intervention of disease, and empowering individuals with information to live the lives they want to live. www.theranos.com